Methodological issues in a comparative study of ziprasidone and risperidone.
Gharabawi
Georges M
GM
Bossie
Cynthia A
CA
Mahmoud
Ramy
R
Canuso
Carla M
CM
Lasser
Robert A
RA
Turkoz
Ibrahim
I
Greenspan
Andrew
A
D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D006801:Humans; D010879:Piperazines / Q000009:adverse effects / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic / Q000592:standards; D012107:Research Design / Q000592:standards*; D018967:Risperidone / Q000009:adverse effects / Q000627:therapeutic use*; D012559:Schizophrenia / Q000188:drug therapy*; D013844:Thiazoles / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome
D014150:Antipsychotic Agents; D010879:Piperazines; D013844:Thiazoles; C092292:ziprasidone; D018967:Risperidone